SynthesisFrontiers in immunology2025

Evaluating the efficacy and safety of immune checkpoint inhibitors in first and second-line treatments for recurrent and metastatic head and neck squamous cell carcinoma: a systematic review and network meta-analysis of RCTs with a focus on PD-L1 expression.

Wei Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.